According to Sonoma Pharmaceuticals's latest financial reports the company's total debt is ยฃ0.22 Million. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-03-31 | ยฃ0.48 M | -30.03% |
2023-03-31 | ยฃ0.68 M | -33.87% |
2022-03-31 | ยฃ1.03 M | -46.41% |
2021-03-31 | ยฃ1.94 M | 183.25% |
2020-03-31 | ยฃ0.68 M | 87.81% |
2019-03-31 | ยฃ0.36 M | -7.41% |
2018-03-31 | ยฃ0.39 M | 20.5% |
2017-03-31 | ยฃ0.32 M | 311.97% |
2016-03-31 | ยฃ0.07 M | 35.25% |
2015-03-31 | ยฃ0.05 M | -33.49% |
2014-03-31 | ยฃ0.08 M | -93.07% |
2013-03-31 | ยฃ1.27 M | -37.12% |
2012-03-31 | ยฃ2.02 M | 27.58% |
2011-03-31 | ยฃ1.58 M | 672.99% |
2010-03-31 | ยฃ0.2 M | -11.36% |
2009-03-31 | ยฃ0.23 M | -79.08% |
2008-03-31 | ยฃ1.1 M | -73.1% |
2007-03-31 | ยฃ4.11 M | 823.73% |
2006-03-31 | ยฃ0.44 M | -43.93% |
2005-03-31 | ยฃ0.79 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |
![]() OPKO Health
OPK | ยฃ0.36 B | 161,502.95% | ๐บ๐ธ USA |